Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort StudyRobert Zangerle, Giota Touloumi, Josiane Warszawski et al.|Clinical Infectious Diseases|2017Cited by 63
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHEREAndrew Atkinson, Luis Prieto, Marcel Zwahlen et al.|Clinical Infectious Diseases|2020Cited by 21
Short-Term Administration of the CCR5 Antagonist Vicriviroc to Patients With HIV and HCV Coinfection Is Safe and TolerableGerd Fätkenheuer, Dirk Schürmann, Jing Li et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2009Cited by 8